On August 8, 2023, the Federal Court overturned Health Canada’s decision that a cannabis product, Edison Jolts, was to be classified as edible cannabis and not cannabis extract. The Court found that Health Canada had breached the duty of procedural fairness by relying on a product classification factor in an internal guidance document that Health
Latest Post
More Posts
Drug advertising: Updated guidance from Health Canada on the distinction between advertising and other activities for health products
Health Canada consulting on wide-ranging regulatory amendments for drugs and medical devices
New interim order continues expedited authorization pathway for COVID-19 medical devices
Health Canada reports on a national strategy for rare disease drugs
Certain COVID-19 medical devices no longer hold urgent public health need status under Interim Order No. 2
Food and Drug Regulations amended: COVID-19 drugs and vaccines transitioned out of interim order framework
Two new interim orders update previous orders on medical devices and foreign products during pandemic
Health Canada consults on proposed guidelines for the use of electronic media in prescription drug labelling
Health Canada consults on transition of interim order drugs, vaccines, and medical devices to permanent approval pathways
Subscribe: Subscribe via RSS
Blogs
Firm/Org